News from the FDA/CDC
News from the FDA/CDC
Adult diabetes up 35% over 25 years
Increases in prevalence significant among whites but not blacks and Mexican-origin adults.
News from the FDA/CDC
U.S. goals for earlier HIV diagnosis and treatment may be out of reach
Only 66% of U.S. youth diagnosed with HIV were introduced to proper care within 90 days of diagnosis, leaving a long way to go to meet the 2020...
News from the FDA/CDC
‘Chronic Lyme’: Serious bacterial infections reported with unproven treatments
Five case reports illustrate the dangers of unproven treatments for so-called chronic Lyme disease.
News
Cotempla XR-ODT approved for children, adolescents with ADHD
Methylphenidate for ADHD now comes in a more convenient disintigrating tablet.
News
FDA advisory committee supports new CV liraglutide indication
A Food and Drug Administration advisory committee voted 17-2 in support of a supplemental new drug application for liraglutide (Victoza)...
News
Mydayis approved for teens, adults with ADHD
Treatment can lead to improved symptoms of ADHD that can last up to 16 hours, phase III studies show.
News from the FDA/CDC
Teens’ overall tobacco use falls, but e-cigs now most popular product
As the use of combustible tobacco products falls, e-cigarettes take the top spot as teens’ tobacco product of choice.
News
BMS recalls a lot of Eliquis 5 mg tablets
The Eliquis 5 mg lot, distributed nationwide, contains the wrong dosage.
News
FDA approves generic version of HIV drug Truvada
The FDA has approved the first generic version of emtricitabine and tenofovir disoproxil fumarate tablets (Truvada) for treating HIV infection.
News from the FDA/CDC
Infant mortality down in most states
No state reported a significant increase in infant mortality between 2005-2007 and 2012-2014.
News from the FDA/CDC
FDA asks drug maker to shelve Opana ER
This marks the first time the agency has acted to remove an opioid pain medication because of the public health consequences of abuse.